Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis

Response and safety of whole‐brain radiotherapy plus temozolomide for patients with brain metastases of non‐small‐cell lung cancer: A meta‐analysis

Abstract Objective The aim of the present work was to investigate the response and safety of whole‐brain radiotherapy (WBRT) plus temozolomide (TMZ) for patients with brain metastases of non‐small‐cell lung cancer (NSCLC). Methods The electronic databases of Pubmed, EMbase, Cochrane, Wangfang, china...

Full description

Bibliographic Details
Main Authors:	Jianguo Han, Ming Qiu, Li Su, Chong Wu, Si Cheng, Zhijun Zhao, Danxia Li, Menghui Wang, Wei Tao, Shiwei Du
Format:	Article
Language:	English
Published:	Wiley 2021-12-01
Series:	Thoracic Cancer
Subjects:	brain metastases meta‐analysis non‐small‐cell lung cancer temozolomide whole‐brain radiotherapy
Online Access:	https://doi.org/10.1111/1759-7714.14183

Similar Items

Pilot study: radiomic analysis for predicting treatment response to whole-brain radiotherapy combined temozolomide in lung cancer brain metastases
by: Yichu Sun, et al.
Published: (2024-08-01)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
by: Yong Xin, et al.
Published: (2018-04-01)

Combining stereotactic radiosurgery and systemic therapy for brain metastases: a potential role for temozolomide
by: Matthew E Hardee, et al.
Published: (2012-08-01)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
by: Xue-Yi Xie, et al.
Published: (2022-07-01)

Whole brain radiotherapy (WBRT) after local treatment of brain metastases in melanoma patients: Statistical Analysis Plan
by: Serigne N. Lo, et al.
Published: (2019-08-01)

Unilateral hippocampal sparing during whole brain radiotherapy for multiple brain metastases: narrative and critical review
by: Petr Pospisil, et al.
Published: (2024-01-01)

Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma
by: Hauswald Henrik, et al.
Published: (2012-08-01)

Hippocampal sparing in whole-brain radiotherapy for brain metastases: controversy, technology and the future
by: Rui Liu, et al.
Published: (2024-01-01)

Untoward global effects of current guideline formulation of stereotactic radiotherapy for symptomatic brain metastases by international medical societies
by: Dorien E.C.M. de Vocht, et al.
Published: (2023-09-01)

The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non‐Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study
by: Lipin Liu, et al.
Published: (2025-01-01)

Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol
by: Brendan Seng Hup Chia, et al.
Published: (2020-10-01)

Is Whole‐Brain Radiotherapy for Brain Metastases an Overestimated Therapy? A Retrospective Study of Real‐World Data Using Landmark Analyses
by: Florian Hoelzl, et al.
Published: (2024-12-01)

Patient reported outcomes following whole brain radiotherapy in patients with brain metastases in NSIA-LUTH Cancer Center
by: Bolanle Adegboyega, et al.
Published: (2023-12-01)

Lymphopenia associated with whole-brain radiotherapy and its effects on clinical outcomes of patients with brain metastases
by: Yue Wang, et al.
Published: (2024-09-01)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
by: Dirk Rades, et al.
Published: (2023-04-01)

The indication of palliative whole-brain radiotherapy for patients with brain metastases: a simple prognostic scoring system in the era of stereotactic radiosurgery
by: Toshiaki Hirose, et al.
Published: (2024-08-01)

Analysis of prognostic factors in patients with brain metastases affecting survival
by: Sweety Gupta, et al.
Published: (2022-11-01)

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
by: Tallet Agnes V, et al.
Published: (2012-05-01)

Optimizing Whole Brain Radiotherapy Treatment and Dose for Patients With Brain Metastases From Small Cell Lung Cancer
by: Hanming Li, et al.
Published: (2021-10-01)

In response to Fogarty et al. and why adjuvant whole brain radiotherapy is not recommended routinely
by: Mark B. Pinkham, et al.
Published: (2017-11-01)

Evaluation of Whole Brain Radiotherapy among Lung Cancer Patients with Brain Metastases in Relation to Health Care Level and Survival
by: Gabriella Frisk, et al.
Published: (2022-04-01)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
by: Binwei Lin, et al.
Published: (2020-04-01)

Different Fractionation in Whole Brain Irradiation for Multiple Brain Metastases
by: Mona Mahmoud Sayed
Published: (2015-04-01)

Role of DOSE Escalation in whole Brain Radiotherapy for Brain Metastasis in Patients with a Favorable Survival Prognosis
by: Saroj Dhaka, et al.
Published: (2022-02-01)

Treatment of brain metastases
by: Marcel Matzenauer, et al.
Published: (2016-12-01)

Lung Cancer with Brain Metastases Treated with Radiotherapy Followed by Bevacizumab Maintenance: A Case Report
by: Sajjad Ahmed Khan, et al.
Published: (2022-06-01)

Editorial: Effects of radiation therapies on brain metastases
by: Rupesh Kotecha, et al.
Published: (2023-04-01)

Cerebellar re-irradiation after whole brain radiotherapy significant symptom relief with minimal toxicity in metastatic brain patients
by: Ory Haisraely, et al.
Published: (2025-02-01)

Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy
by: Yi‐Chun Hua, et al.
Published: (2023-11-01)

Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases
by: Yu Wang, et al.
Published: (2023-09-01)

Radiotherapy management of brain metastases using conventional linear accelerator
by: Marcel Matzenauer, et al.
Published: (2016-09-01)

Survival and intracranial control outcomes of whole-brain radiotherapy (WBRT) alone versus WBRT plus a radiotherapy boost in non-small-cell lung cancer with brain metastases: a single-institution retrospective analysis
by: Lu F, et al.
Published: (2019-05-01)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
by: Muhammad Khan, et al.
Published: (2019-03-01)

A Pituitary Carcinoma Patient With Cerebrospinal Fluid Dissemination Showing a Good Response to Temozolomide Combined With Whole-Brain and Spinal Cord Radiotherapy: A Case Report and Literature Review
by: Peng Du, et al.
Published: (2022-07-01)

The Cognitive Effects of Radiotherapy for Brain Metastases
by: Eric J. Lehrer, et al.
Published: (2022-06-01)

Anlotinib combined with whole-brain radiotherapy in non-small cell lung cancer with multiple brain metastases that progressed or developed after at least one lines of prior treatment
by: Cheng Kong, et al.
Published: (2023-09-01)

Stereotactic radiotherapy for brain metastases: predictive factors of radionecrosis
by: Benoît Calderon, et al.
Published: (2023-07-01)

Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters
by: Jiang Xue-song, et al.
Published: (2012-03-01)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
by: Ashwin Shinde, et al.
Published: (2019-03-01)

Metastatic brain tumor. Clinical features, diagnosis and treatment
by: Andrey V. Golanov, et al.
Published: (2023-05-01)